CPRT(CPRT)
CPRT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $4.83B | $5.12B | $5.30B | $5.47B |
| Low | $4.63B | $4.99B | $5.02B | $5.26B |
| High | $5.09B | $5.37B | $5.59B | $5.69B |
| EBITDA Avg | $2.16B | $2.29B | $2.38B | $2.45B |
| Low | $2.07B | $2.24B | $2.25B | $2.36B |
| High | $2.28B | $2.41B | $2.51B | $2.55B |
| EBIT Avg | $1.95B | $2.07B | $2.15B | $2.22B |
| Low | $1.87B | $2.02B | $2.03B | $2.13B |
| High | $2.06B | $2.18B | $2.26B | $2.31B |
| Net Income Avg | $1.56B | $1.81B | $1.97B | $2.14B |
| Low | $1.52B | $1.75B | $1.92B | $2.03B |
| High | $1.67B | $1.87B | $2.03B | $2.25B |
| EPS Avg | $1.67 | $1.85 | $2.02 | $2.19 |
| Low | $1.56 | $1.79 | $1.96 | $2.08 |
| High | $1.71 | $1.91 | $2.08 | $2.30 |
| Analysts (Rev / EPS) | 9 / 9 | 4 / 4 | 2 / 2 | 1 / 1 |
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 |
|---|---|---|---|---|
| Revenue Avg | $1.18B | $1.17B | $1.28B | $1.21B |
| Low | $1.16B | $1.15B | $1.26B | $1.19B |
| High | $1.21B | $1.20B | $1.31B | $1.24B |
| EBITDA Avg | $531M | $524M | $574M | $543M |
| Low | $522M | $515M | $564M | $534M |
| High | $545M | $537M | $588M | $556M |
| EBIT Avg | $480M | $473M | $519M | $491M |
| Low | $471M | $465M | $510M | $482M |
| High | $492M | $485M | $531M | $502M |
| Net Income Avg | $395M | $378M | $435M | $399M |
| Low | $366M | $369M | $425M | $390M |
| High | $423M | $390M | $449M | $411M |
| EPS Avg | $0.41 | $0.39 | $0.45 | $0.41 |
| Low | $0.38 | $0.38 | $0.44 | $0.40 |
| High | $0.44 | $0.40 | $0.46 | $0.43 |
| Analysts (Rev / EPS) | 4 / 5 | 2 / 3 | 2 / 3 | 2 / 3 |